Form D — Avenue Biosciences Holding Inc
0002101752-26-000001 · filed Jan 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $8,357,349
- Total sold
- $7,440,682
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Avenue Biosciences Holding Inc
- CIK
- 2101752
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 211 LAUREL STREET
MENLO PARK, CA 94025 - Phone
- 6502858564
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Tero-Pekka Alastalo · Executive OfficerMenlo Park, CA Find on LinkedIn ↗
-
Katja Rosti · Executive OfficerHelsinki, H9 Find on LinkedIn ↗
-
Gabriel Poteliunaite · DirectorGdansk, R9 Find on LinkedIn ↗
-
Jenny Engerfelt · DirectorBorensberg, V7 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗